Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: quidditch who wrote (2800)	5/17/1999 1:27:00 PM
From: Don Miller	Respond to of 10280

News, 424B3 Filing posted by Company, partial copy below: Full link is corporate-ir.net PROSPECTUS SUPPLEMENT (TO PROSPECTUS DATED JUNE 18, 1998) SEPRACOR INC. ---------------------------------------- $189,475,000 PRINCIPAL AMOUNT OF 6 1/4% CONVERTIBLE SUBORDINATED DEBENTURES DUE 2005 (Interest payable August 15 and February 15) ---------------------------------------- 4,012,617 Shares of Common Stock ($0.10 par value per share) --------------------- The information in this Prospectus Supplement concerning the Selling Securityholders supplements the statements set forth under the caption "Selling Securityholders" in the Prospectus. Capitalized items used and not defined herein shall have the meanings given to them in the Prospectus. The information set forth under the caption "Selling Securityholders" in the Prospectus is supplemented as follows: SELLING SECURITYHOLDERS The Debentures were originally acquired on February 10, 1998 from the Company by the Initial Purchasers. The Initial Purchasers advised the Company that the Initial Purchasers have resold the Debentures in transactions exempt from the registration requirements of the Securities Act to "qualified institutional buyers" (as defined in Rule 144A of the Securities Act) and certain institutional "accredited investors" (as defined in Rule 501(a)(1), (2), (3), or (7) under the Securities Act). These subsequent purchasers, or their transferees, pledgees, donees or successors, may from time to time offer and sell any or all of the Debentures and/or Conversion Shares pursuant to this Prospectus.